Study of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients: Sarilumab, Azithromycin, Hydroxychloroquine Trial - CORIMUNO-19 - VIRO
Clinical trial NCT04341870 · SUSPENDED
Trial details
- NCT number
- NCT04341870
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- SUSPENDED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-11
- Primary completion
- 2020-05-08
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.